A subsidiary of the University Medical Center Hamburg-Eppendorf

Arzt betritt OP-Raum

Treatment options for prostate cancer – an overview

Successful treatment all depends on your age and operative risk, the rate at which your tumour is growing, your personal circumstances and any potential comorbidities. We will consider these criteria in an initial consultation with you. We will provide detailed information you can trust about the different established treatment methods available to you, along with their potential benefits and drawbacks.

There are five scientifically researched strategies for treating localised prostate carcinoma, which we will present to you in detail. 

How is my cancer classified?

We use a variety of metrics to determine which of the three risk groups you are in. This in turn dictates which treatment options would be most suitable for you.

Martini-Klinik

Accompanies you through this topic

Prof. Dr. Hans Heinzer
Faculty member

An overview of treatment options

There are five scientifically researched strategies for treating localised prostate carcinoma, which we will present to you in detail.

Last but not least a radiotherapy – administered externally through the skin (percutaneously). Radiation therapy can be used as an alternative to surgery in the primary treatment of prostate carcinoma and in locally advanced tumor stages after prostatectomy and in recurrences. 

What treatment options are available for prostate cancer?

Successful treatment all depends on your age and operative risk, the rate at which your tumour is growing, your personal circumstances and any potential comorbidities. We will consider these criteria in an initial consultation with you. 

There are five scientifically researched treatment options available: prostatectomy, the complete (radical) surgical removal of the prostate; radiotherapy, which is administered externally through the skin (percutaneously); brachytherapy, a form of radiotherapy administered from within using either a low-dose rate (LDR) or a high-dose rate (HDR); focal therapy, which is treatment to remove a tumour lesion localised in the prostate, and active surveillance, which means waiting and observing the tumour.